Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Carter

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Rheumatology|August 20, 2011
Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?John D Carter, Hervé C Gérard, Judith A Whittum-Hudson, et al.
Rheumatic Diseases Clinics of North America|June 2, 2009
Molecular biology of infectious agents in chronic arthritisHervé C Gérard, Judith A Whittum-Hudson, John D Carter, et al.
The Journal of Rheumatology|January 10, 2009
A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration databaseJohn D Carter, Anil Ladhani, Louis R Ricca, et al.
International Journal of Clinical Rheumatology|February 27, 2013
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritisJohn D Carter, Herve C Gerard, Judith A Whittum-Hudson, et al.
Inflammatory Bowel Diseases|December 20, 2008
Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)?Stephanie Ingram, Joseph M McKinley, Frank Vasey, et al.
Journal of Clinical Gastroenterology|April 19, 2003
Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximabLaura McIlwain, John D Carter, Syed Bin-Sagheer, et al.
Journal of the American Chemical Society|January 26, 2007
Understanding the selectivity of a moderate oxidation catalyst: hydrogen abstraction by a fully characterized, activated catalyst, the robust dihydroxo manganese(IV) complex of a bridged cyclamGuochuan Yin, Andrew M Danby, David Kitko, et al.
The Journal of Rheumatology|July 3, 2013
Attack rate of Chlamydia-induced reactive arthritis and effect of the CCR5-Delta-32 mutation: a prospective analysisJohn D Carter, Aasim Rehman, Jason P Guthrie, et al.
Journal of the American Chemical Society|November 13, 2008
Oxidative reactivity difference among the metal oxo and metal hydroxo moieties: pH dependent hydrogen abstraction by a manganese(IV) complex having two hydroxide ligandsGuochuan Yin, Andrew M Danby, David Kitko, et al.
Inorganic Chemistry|February 14, 2007
Olefin epoxidation by alkyl hydroperoxide with a novel cross-bridged cyclam manganese complex: demonstration of oxygenation by two distinct reactive intermediatesGuochuan Yin, Andrew M Danby, David Kitko, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Rheumatology|August 20, 2011
Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?John D Carter, Hervé C Gérard, Judith A Whittum-Hudson, et al.
Rheumatic Diseases Clinics of North America|June 2, 2009
Molecular biology of infectious agents in chronic arthritisHervé C Gérard, Judith A Whittum-Hudson, John D Carter, et al.
The Journal of Rheumatology|January 10, 2009
A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration databaseJohn D Carter, Anil Ladhani, Louis R Ricca, et al.
International Journal of Clinical Rheumatology|February 27, 2013
The molecular basis for disease phenotype in chronic Chlamydia-induced arthritisJohn D Carter, Herve C Gerard, Judith A Whittum-Hudson, et al.
Inflammatory Bowel Diseases|December 20, 2008
Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)?Stephanie Ingram, Joseph M McKinley, Frank Vasey, et al.
Journal of Clinical Gastroenterology|April 19, 2003
Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximabLaura McIlwain, John D Carter, Syed Bin-Sagheer, et al.
Journal of the American Chemical Society|January 26, 2007
Understanding the selectivity of a moderate oxidation catalyst: hydrogen abstraction by a fully characterized, activated catalyst, the robust dihydroxo manganese(IV) complex of a bridged cyclamGuochuan Yin, Andrew M Danby, David Kitko, et al.
The Journal of Rheumatology|July 3, 2013
Attack rate of Chlamydia-induced reactive arthritis and effect of the CCR5-Delta-32 mutation: a prospective analysisJohn D Carter, Aasim Rehman, Jason P Guthrie, et al.
Journal of the American Chemical Society|November 13, 2008
Oxidative reactivity difference among the metal oxo and metal hydroxo moieties: pH dependent hydrogen abstraction by a manganese(IV) complex having two hydroxide ligandsGuochuan Yin, Andrew M Danby, David Kitko, et al.
Inorganic Chemistry|February 14, 2007
Olefin epoxidation by alkyl hydroperoxide with a novel cross-bridged cyclam manganese complex: demonstration of oxygenation by two distinct reactive intermediatesGuochuan Yin, Andrew M Danby, David Kitko, et al.
Pageof 6